Inventor
JOHNSON AMY S
US18 patents
Patents
18 patentsUS11958894B2Apr 16, 2024
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA5 citations93
US11753459B2Sep 12, 2023
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA5 citations93
US10927342B2Feb 23, 2021
Taurine supplemented cell culture medium and methods of use
REGENERON PHARMA23 citations92
US12012444B2Jun 18, 2024
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA2 citations83
US12338274B2Jun 24, 2025
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA0 citations72
US12319728B2Jun 3, 2025
Anti-VEGF protein compositions and methods for producing the same
REGENERON PHARMA0 citations72
US12331341B2Jun 17, 2025
Serum-free cell culture medium
REGENERON PHARMA2 citations71
US11312936B2Apr 26, 2022
Taurine supplemented cell culture medium and methods of use
REGENERON PHARMA1 citations71
US11332771B2May 17, 2022
Serum-free cell culture medium
REGENERON PHARMA3 citations69
US11390663B2Jul 19, 2022
Metabolically optimized cell culture
REGENERON PHARMA1 citations66
US12577528B2Mar 17, 2026
Taurine supplemented cell culture medium and methods of use
REGENERON PHARMA0 citations60
US12359165B2Jul 15, 2025
Taurine supplemented cell culture medium and methods of use
REGENERON PHARMA0 citations60
US12359166B2Jul 15, 2025
Taurine supplemented cell culture medium and methods of use
REGENERON PHARMA0 citations60
US12221619B2Feb 11, 2025
Taurine supplemented cell culture medium and methods of use
REGENERON PHARMA0 citations60
US11970724B2Apr 30, 2024
Serum-free cell culture medium
REGENERON PHARMA0 citations59
US12545717B2Feb 10, 2026
Metabolically optimized cell culture
REGENERON PHARMA0 citations56
US12291563B2May 6, 2025
Metabolically optimized cell culture
REGENERON PHARMA0 citations56
US12163122B2Dec 10, 2024
Asparagine feed strategies to improve cell culture performance and mitigate asparagine sequence variants
REGENERON PHARMA1 citations55